Identification of Novel Somatic <i>TP53</i> Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS). This evidence concerns the gene TP53 and ovarian serous adenocarcinoma.